Salient Pharmaceuticals Incorporated
2 clinical trials · Sponsor
◉ Watch Salient Pharmaceuticals Incorporated
| Record | Firm | Date |
|---|---|---|
| The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer (NCT01739634) | Salient Pharmaceuticals Incorporated | 2012-11-01 |
| Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal (CASAD) for Treatment of Clostridium Difficile Infection (NCT01570634) | Salient Pharmaceuticals Incorporated | 2012-03-01 |
Track Salient Pharmaceuticals Incorporated automatically
Every clearance here is in the API, with alerts when new ones post.